WTIM
EW icon

Wilmington Trust Investment Management’s Edwards Lifesciences EW Stock Holding History

Wilmington Trust Investment Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		$269K Buy
+18,804
New +$255K 0.05% 273

Other funds holding EW

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
FC
Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wilmington Trust Investment Management's EW Position: Q2 2014 in Review

Wilmington Trust Investment Management opened a new position in Edwards Lifesciences (EW) in Q2 2014: 18,804 shares worth $269K. The stake represents 0.05% of the portfolio and ranks #273 among its holdings.

429 funds tracked by Wall St. Rank hold EW as of Q2 2014.

  • Wilmington Trust Investment Management held 18,804 shares of Edwards Lifesciences worth $269K as of Q2 2014.
  • Edwards Lifesciences was a new Wilmington Trust Investment Management position in Q2 2014.
  • Edwards Lifesciences made up 0.05% of Wilmington Trust Investment Management's portfolio in Q2 2014, its #273 holding.
  • 429 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2014.

Based on Wilmington Trust Investment Management's 13F filing for Q2 2014, filed 13 Aug 2014.